Stage III Childhood Lymphoblastic Lymphoma Completed Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0030479 (Stage III Childhood Lymphoblastic Lymphoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs